Media Contact
Press Releases
- Pear Therapeutics Announces Publication of New Analysis of Real-World Data Showing Reduction in Insomnia Severity, Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® August 10, 2022
- Pear Therapeutics and SelectHealth Announce Coverage to Provide Access to FDA-Authorized Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder August 8, 2022
- PEAR THERAPEUTICS AND COVE BEHAVIORAL HEALTH TO PROVIDE PATIENTS ACCESS TO PRESCRIPTION DIGITAL THERAPEUTIC FOR THE TREATMENT OF OPIOID USE DISORDER August 3, 2022
- PEAR THERAPEUTICS TO BE ADDED TO RUSSELL US INDEX SERIES August 2, 2022
- PEAR THERAPEUTICS TO ISSUE SECOND QUARTER 2022 FINANCIAL RESULTS ON THURSDAY, AUGUST 11, 2022 July 28, 2022
- PEAR THERAPEUTICS TO PARTICIPATE IN THE COWEN 7TH ANNUAL FUTUREHEALTH CONFERENCE June 16, 2022